Azenta to Participate in the BTIG MedTech, Digital Health, Life Science & Diagnostic Tools Conference

Rhea-AI Summary

Azenta, Inc. (Nasdaq: AZTA) will participate in the BTIG MedTech, Digital Health, Life Science & Diagnostic Tools Conference on February 15-16, 2023. Interested participants should contact their BTIG representative to attend. Azenta is recognized globally for providing life sciences solutions, facilitating faster market delivery of breakthroughs and therapies. Their comprehensive offerings include cold-chain sample management and genomic services, primarily serving pharmaceutical, biotech, academic, and healthcare institutions worldwide. The company is based in Burlington, MA, with operations spanning North America, Europe, and Asia.

News Market Reaction – AZTA

-2.48%

-2.48% Session move

In the trading session that priced this news, AZTA declined 2.48%, reflecting a moderate negative market reaction.

Data tracked by StockTitan Argus on the day of publication.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

BURLINGTON, Mass., Feb. 10, 2023 /PRNewswire/ -- Azenta, Inc. (Nasdaq: AZTA) today announced that Company management will participate in the BTIG MedTech, Digital Health, Life Science & Diagnostic Tools Conference on February 15-16, 2023. To attend the event please contact your BTIG representative.

About Azenta Life Sciences

Azenta, Inc. (Nasdaq: AZTA) is a leading provider of life sciences solutions worldwide, enabling impactful breakthroughs and therapies to market faster. Azenta provides a full suite of reliable cold-chain sample management solutions and genomic services across areas such as drug development, clinical research and advanced cell therapies for the industry's top pharmaceutical, biotech, academic and healthcare institutions globally.

Azenta is headquartered in Burlington, MA, with operations in North America, Europe and Asia. For more information, please visit www.azenta.com.

INVESTOR CONTACTS:
Sara Silverman
Head of Investor Relations & Corporate Communications
ir@azenta.com

Sherry Dinsmore
sherry.dinsmore@azenta.com

 

View original content to download multimedia:https://www.prnewswire.com/news-releases/azenta-to-participate-in-the-btig-medtech-digital-health-life-science--diagnostic-tools-conference-301743760.html

SOURCE Azenta

FAQ

When is Azenta participating in the BTIG MedTech Conference?

Azenta will participate in the BTIG MedTech Conference on February 15-16, 2023.

Where is Azenta headquartered?

Azenta is headquartered in Burlington, Massachusetts.

What does Azenta, symbol AZTA, specialize in?

Azenta specializes in life sciences solutions, including cold-chain sample management and genomic services.

Who can attend the BTIG MedTech Conference with Azenta?

Interested attendees should contact their BTIG representative to participate.

Which regions does Azenta operate in?

Azenta operates in North America, Europe, and Asia.